Electra Therapeutics, Inc. · NASDAQ:ETRA
Gordon Carl L bought 472,571 Electra Therapeutics, Inc. shares (Form 4)
Traded Nov 3 to Nov 5, 2026 · Filed Nov 5, 2026
From Nov 3 to Nov 5, 2026, Gordon Carl L (Director, 10% owner) bought 472,571 Electra Therapeutics, Inc. shares at an average US$7.63 for US$3.61M, leaving 2,136,979 shares. Filed Nov 5, 2026 (Form 4).
- Bought
- 472,571 shares
- Price
- US$7.63 average (US$7.07 to US$7.88)
- Value
- US$3.61M
- Holding after
- 2,136,979 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | Common Stock | Buy | 24,313 | US$7.84 | 5,151,204 | Indirect |
| Nov 3, 2026 | Common Stock | Buy | 97,800 | US$7.84 | 1,856,079 | Indirect |
| Nov 3, 2026 | Common Stock | Buy | 24,400 | US$7.88 | 5,175,604 | Indirect |
| Nov 3, 2026 | Common Stock | Buy | 98,600 | US$7.88 | 1,954,679 | Indirect |
| Nov 4, 2026 | Common Stock | Buy | 9,267 | US$7.78 | 5,184,871 | Indirect |
| Nov 4, 2026 | Common Stock | Buy | 37,100 | US$7.78 | 1,991,779 | Indirect |
| Nov 4, 2026 | Common Stock | Buy | 5,000 | US$7.07 | 5,189,871 | Indirect |
| Nov 4, 2026 | Common Stock | Buy | 20,000 | US$7.07 | 2,011,779 | Indirect |
| Nov 5, 2026 | Common Stock | Buy | 30,891 | US$7.31 | 5,220,762 | Indirect |
| Nov 5, 2026 | Common Stock | Buy | 125,200 | US$7.31 | 2,136,979 | Indirect |
Source
Download original · View original at SEC
Related
- Electra Therapeutics, Inc.
- Gordon Carl L
- Electra Therapeutics, Inc. shareholders
- Form 4 · Gordon Carl L · Nov 10, 2026
- Form 4 · Gordon Carl L · Sep 23, 2026
- Schedule 13G · Cormorant Asset Management, LP · Nov 16, 2026
- Form 4 · Orbimed Advisors LLC · Nov 10, 2026
- Form 4 · Orbimed Advisors LLC · Nov 5, 2026
- Schedule 13G · Dr. Beth C. Seidenberg · Oct 29, 2026
- Schedule 13G · LSP 7 Cooperatief U.A. · Sep 28, 2026